Critical Role for CD1d-Restricted Invariant NKT Cells in Stimulating Intrahepatic CD8 T-Cell Responses to Liver Antigen

Gastroenterology

Volumn 134, Issue 7, 2008, Pages 2132-2143

  Sprengers, Dave ^a,b   Sillé, Fenna C M ^a   Derkow, Katja ^c   Besra, Gurdyal S ^d   Janssen, Harry L A ^b   Schott, Eckart ^c   Boes, Marianne ^a,e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; GAMMA INTERFERON; LIVER ANTIGEN; OVALBUMIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; IMMUNOSTIMULATION; LIVER INJURY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 44649186384     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.02.037     Document Type: Article

References (38)

1. Brossay L., Burdin N., Tangri S., et al. Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands. Immunol Rev 163 (1998) 139-150
2. Kronenberg M., and Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2 (2002) 557-568
3. Matsuda J.L., Naidenko O.V., Gapin L., et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192 (2000) 741-754
4. Bendelac A., Rivera M.N., Park S.H., et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15 (1997) 535-562
5. Carnaud C., Lee D., Donnars O., et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163 (1999) 4647-4650
6. Hermans I.F., Silk J.D., Gileadi U., et al. NKT cells enhance CD4+ and CD8+ T-cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171 (2003) 5140-5147
7. Fujii S., Shimizu K., Smith C., et al. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T-cell immunity to a coadministered protein. J Exp Med 198 (2003) 267-279
8. Nakagawa R., Nagafune I., Tazunoki Y., et al. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol 166 (2001) 6578-6584
9. Smyth M.J., Crowe N.Y., Pellicci D.G., et al. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99 (2002) 1259-1266
10. Exley M.A., Bigley N.J., Cheng O., et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 69 (2001) 713-718
11. Grubor-Bauk B., Simmons A., Mayrhofer G., et al. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V α 14-J α 281 TCR. J Immunol 170 (2003) 1430-1434
12. Nieuwenhuis E.E., Neurath M.F., Corazza N., et al. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci U S A 99 (2002) 16951-16956
13. Kakimi K., Lane T.E., Chisari F.V., et al. Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167 (2001) 6701-6705
14. Kita H., Naidenko O.V., Kronenberg M., et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123 (2002) 1031-1043
15. Lucas M., Gadola S., Meier U., et al. Frequency and phenotype of circulating Vα24/Vβ11 double-positive natural killer T cells during hepatitis C virus infection. J Virol 77 (2003) 2251-2257
16. Nuti S., Rosa D., Valiante N.M., et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 28 (1998) 3448-3455
17. Crispe I.N., Giannandrea M., Klein I., et al. Cellular and molecular mechanisms of liver tolerance. Immunol Rev 213 (2006) 101-118
18. Derkow K., Loddenkemper C., Mintern J., et al. Differential priming of CD8 and CD4 T cells in animal models of autoimmune hepatitis and cholangitis. Hepatology 46 (2007) 1155-1165
19. Cyster J.G. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23 (2005) 127-159
20. Hogquist K.A., Jameson S.C., Heath W.R., et al. T-cell receptor antagonist peptides induce positive selection. Cell 76 (1994) 17-27
21. Lanzavecchia A., and Sallusto F. Regulation of T-cell immunity by dendritic cells. Cell 106 (2001) 263-266
22. Gallatin W.M., Weissman I.L., and Butcher E.C. A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature 304 (1983) 30-34
23. Matloubian M., Lo C.G., Cinamon G., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427 (2004) 355-360
24. Osman Y., Kawamura T., Naito T., et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 30 (2000) 1919-1928
25. Fujii H., Seki S., and Kobayashi S. A murine model of NKT cell-mediated liver injury induced by α-galactosylceramide/d-galactosamine. Virchows Arch 446 (2005) 663-673
26. Inui T., Nakagawa R., Ohkura S., et al. Age-associated augmentation of the synthetic ligand- mediated function of mouse NK1.1 ag(+) T cells: their cytokine production and hepatotoxicity in vivo and in vitro. J Immunol 169 (2002) 6127-6132
27. Inui T., Nakashima H., Habu Y., et al. Neutralization of tumor necrosis factor abrogates hepatic failure induced by α-galactosylceramide without attenuating its antitumor effect in aged mice. J Hepatol 43 (2005) 670-678
28. Bowen D.G., Zen M., Holz L., et al. The site of primary T-cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114 (2004) 701-712
29. Klein I., Gassel H.J., and Crispe I.N. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming. Transplant Proc 38 (2006) 3241-3243
30. Wuensch S.A., Pierce R.H., and Crispe I.N. Local intrahepatic CD8+ T-cell activation by a non-self-antigen results in full functional differentiation. J Immunol 177 (2006) 1689-1697
31. Nakagawa R., Inui T., Nagafune I., et al. Essential role of bystander cytotoxic CD122+CD8+ T cells for the antitumor immunity induced in the liver of mice by α-galactosylceramide. J Immunol 172 (2004) 6550-6557
32. Trobonjaca Z., Leithauser F., Moller P., et al. Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J Immunol 167 (2001) 1413-1422
33. Schmieg J., Yang G., Franck R.W., et al. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci U S A 102 (2005) 1127-1132
34. Winau F., Hegasy G., Weiskirchen R., et al. Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26 (2007) 117-129
35. Hayakawa Y., Takeda K., Yagita H., et al. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur J Immunol 31 (2001) 1720-1727
36. Biburger M., and Tiegs G. α-Galactosylceramide-induced liver injury in mice is mediated by TNF-α but independent of Kupffer cells. J Immunol 175 (2005) 1540-1550
37. Bertoletti A., and Ferrari C. Kinetics of the immune response during HBV and HCV infection. Hepatology 38 (2003) 4-13
38. Van Kaer L. α-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 5 (2005) 31-42